| Title : Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years - Wattmo_2017_Alzheimers.Res.Ther_9_70 |
| Author(s) : Wattmo C , Wallin AK |
| Ref : Alzheimers Res Ther , 9 :70 , 2017 |
| Abstract : |
| PubMedSearch : Wattmo_2017_Alzheimers.Res.Ther_9_70 |
| PubMedID: 28859660 |
| Title : Early-versus Late-Onset Alzheimer Disease: Long-Term Functional Outcomes, Nursing Home Placement, and Risk Factors for Rate of Progression - Wattmo_2017_Dement.Geriatr.Cogn.Dis.Extra_7_172 |
| Author(s) : Wattmo C , Wallin AK |
| Ref : Dement Geriatr Cogn Dis Extra , 7 :172 , 2017 |
| Abstract : |
| PubMedSearch : Wattmo_2017_Dement.Geriatr.Cogn.Dis.Extra_7_172 |
| PubMedID: 28626471 |
| Title : Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy - Wattmo_2016_Alzheimers.Res.Ther_8_7 |
| Author(s) : Wattmo C , Minthon L , Wallin AK |
| Ref : Alzheimers Res Ther , 8 :7 , 2016 |
| Abstract : |
| PubMedSearch : Wattmo_2016_Alzheimers.Res.Ther_8_7 |
| PubMedID: 26883213 |
| Title : Progression of mild Alzheimer's disease: knowledge and prediction models required for future treatment strategies - Wattmo_2013_Alzheimers.Res.Ther_5_44 |
| Author(s) : Wattmo C , Wallin AK , Minthon L |
| Ref : Alzheimers Res Ther , 5 :44 , 2013 |
| Abstract : |
| PubMedSearch : Wattmo_2013_Alzheimers.Res.Ther_5_44 |
| PubMedID: 24099236 |
| Title : Dose and plasma concentration of galantamine in Alzheimer's disease - clinical application - Wattmo_2013_Alzheimers.Res.Ther_5_2 |
| Author(s) : Wattmo C , Jedenius E , Blennow K , Wallin AK |
| Ref : Alzheimers Res Ther , 5 :2 , 2013 |
| Abstract : |
| PubMedSearch : Wattmo_2013_Alzheimers.Res.Ther_5_2 |
| PubMedID: 23286718 |
| Title : Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort - Wattmo_2012_BMC.Neurol_12_134 |
| Author(s) : Wattmo C , Wallin AK , Minthon L |
| Ref : BMC Neurol , 12 :134 , 2012 |
| Abstract : |
| PubMedSearch : Wattmo_2012_BMC.Neurol_12_134 |
| PubMedID: 23126532 |
| Title : Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease - Parnetti_2011_Acta.Neurol.Scand_124_122 |
| Author(s) : Parnetti L , Chiasserini D , Andreasson U , Ohlson M , Huls C , Zetterberg H , Minthon L , Wallin AK , Andreasen N , Talesa VN , Blennow K |
| Ref : Acta Neurologica Scandinavica , 124 :122 , 2011 |
| Abstract : |
| PubMedSearch : Parnetti_2011_Acta.Neurol.Scand_124_122 |
| PubMedID: 20880294 |
| Title : Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment - Wattmo_2011_Gerontologist_51_17 |
| Author(s) : Wattmo C , Wallin AK , Londos E , Minthon L |
| Ref : Gerontologist , 51 :17 , 2011 |
| Abstract : |
| PubMedSearch : Wattmo_2011_Gerontologist_51_17 |
| PubMedID: 20562471 |
| Title : Galantamine treatment in Alzheimer's disease: response and long-term outcome in a routine clinical setting - Wallin_2011_Neuropsychiatr.Dis.Treat_7_565 |
| Author(s) : Wallin AK , Wattmo C , Minthon L |
| Ref : Neuropsychiatr Dis Treat , 7 :565 , 2011 |
| Abstract : |
| PubMedSearch : Wallin_2011_Neuropsychiatr.Dis.Treat_7_565 |
| PubMedID: 22003296 |
| Title : Predictors of long-term cognitive outcome in Alzheimer's disease - Wattmo_2011_Alzheimers.Res.Ther_3_23 |
| Author(s) : Wattmo C , Wallin AK , Londos E , Minthon L |
| Ref : Alzheimers Res Ther , 3 :23 , 2011 |
| Abstract : |
| PubMedSearch : Wattmo_2011_Alzheimers.Res.Ther_3_23 |
| PubMedID: 21774798 |
| Title : CSF biomarkers predict a more malignant outcome in Alzheimer disease - Wallin_2010_Neurology_74_1531 |
| Author(s) : Wallin AK , Blennow K , Zetterberg H , Londos E , Minthon L , Hansson O |
| Ref : Neurology , 74 :1531 , 2010 |
| Abstract : |
| PubMedSearch : Wallin_2010_Neurology_74_1531 |
| PubMedID: 20458070 |
| Title : Can CSF biomarkers or pre-treatment progression rate predict response to cholinesterase inhibitor treatment in Alzheimer's disease? - Wallin_2009_Int.J.Geriatr.Psychiatry_24_638 |
| Author(s) : Wallin AK , Hansson O , Blennow K , Londos E , Minthon L |
| Ref : Int J Geriatr Psychiatry , 24 :638 , 2009 |
| Abstract : |
| PubMedSearch : Wallin_2009_Int.J.Geriatr.Psychiatry_24_638 |
| PubMedID: 19123199 |
| Title : Predicting long-term cognitive outcome with new regression models in donepezil-treated Alzheimer patients in a naturalistic setting - Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203 |
| Author(s) : Wattmo C , Hansson O , Wallin AK , Londos E , Minthon L |
| Ref : Dementia & Geriatric Cognitive Disorders , 26 :203 , 2008 |
| Abstract : |
| PubMedSearch : Wattmo_2008_Dement.Geriatr.Cogn.Disord_26_203 |
| PubMedID: 18769065 |
| Title : Five-year outcome of cholinergic treatment of Alzheimer's disease: early response predicts prolonged time until nursing home placement, but does not alter life expectancy - Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197 |
| Author(s) : Wallin AK , Gustafson L , Sjogren M , Wattmo C , Minthon L |
| Ref : Dementia & Geriatric Cognitive Disorders , 18 :197 , 2004 |
| Abstract : |
| PubMedSearch : Wallin_2004_Dement.Geriatr.Cogn.Disord_18_197 |
| PubMedID: 15211076 |